GSK plc - 11 Dec 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
10%+ Owner
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
Issuer symbol
WVE
Transactions as of
11 Dec 2025
Net transactions value
+$27,930,000
Form type
4
Filing time
15 Dec 2025, 16:32:10 UTC
Previous filing
01 Oct 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GSK plc 10%+ Owner 79 NEW OXFORD STREET, LONDON, UNITED KINGDOM /s/ Victoria Whyte, Authorized Signatory, GSK plc 15 Dec 2025 0001131399

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Purchase $27,930,000 +1,470,000 +8.8% $19.00 18,245,691 11 Dec 2025 By Corporation F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

GSK plc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").